Michael Robinson has been following, talking with and advising global technology companies for years.
Indeed, he's so well connected that here at Money Map Press we often refer to him as "Our Man in Silicon Valley."
But of all the opportunities emerging in today's technology-dominated "Convergence Economy," there's one that Michael says has years of robust growth to come.
We're talking, of course, about biotech.
In this wide-ranging interview with Money Map Press Executive Editor William Patalon III, Michael - who runs our Nova-X Report and Radical Technology Profits advisory services - shares several stock recommendations and talks about the single-biggest investment opportunity he sees.
